These can be reversed by inhibiting PAI-1 activity using small-molecule inhibitors [82,83,84,85] suggesting that the tPA/PAI-1 system is a potential therapeutic target for many pathological conditions, such as cardiovascular diseases, metabolic disorders, fibrosis, cancer, and inflammatory and infectious diseases (Table 1). Here, SERPINE1 is linked to infectious disease.